Pharmaceutical company Wockhardt has reported a
consolidated net loss of Rs 192 crore for the fourth quarter of FY12 as against
profit of Rs 162 crore in the corresponding quarter of last fiscal, due to
exceptional loss of Rs 450 crore during the quarter.
Consolidated net sales increased 32% year-on-year to Rs
1,241 crore in the quarter ended March 2012.
EBITDA margins improved at 35% in the January-March quarter
of 2012 as against 29% in a year ago period.
Wockhardt earning a forex gain of Rs 55 crore during the
quarter.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment